SML1094

CHIR 98014

≥98% (HPLC), powder, GSK-3 inhibitor

• Synonym(e): N-6-[2-[[4-(2,4-Dichlorophenyl)-5-(1H-imidazol-1-yl)-2-pyrimidinyl]amino]ethyl]-3-nitro-2,6-pyridinediamine, CHIR-98014
• Empirische Formel (Hill-System): C₂₀H₁₇Cl₂N₉O₂
• CAS-Nummer: 252935-94-7
• Molekulargewicht: 486.31
• MDL-Nummer: MFCD10565922
• UNSPSC-Code: 12352200
• PubChem Substanz-ID: 329825471
• NACRES: NA.77

Eigenschaften

• product name: CHIR 98014, ≥98% (HPLC)
• Qualitätsniveau: 200
• Assay: ≥98% (HPLC)
• Form: powder
• Farbe: white to brown
• Löslichkeit: DMSO: 0.5 mg/mL, clear (warmed)
• Lagertemp.: −20°C
• SMILES String: NC1=C(C=CC(NCCNC2=NC(C3=C(Cl)C=C(Cl)C=C3)=C(N4C=CN=C4)C=N2)=N1)[N+]([O-])=O
• InChI: 1S/C20H17Cl2N9O2/c21-12-1-2-13(14(22)9-12)18-16(30-8-7-24-11-30)10-27-20(29-18)26-6-5-25-17-4-3-15(31(32)33)19(23)28-17/h1-4,7-11H,5-6H2,(H3,23,25,28)(H,26,27,29)
• InChIKey: MDZCSIDIPDZWKL-UHFFFAOYSA-N

Beschreibung

Anwendung

CHIR 98014 has been used for the generation of small molecules neural progenitor cells and differentiation towards motor neurons. It has also been used as a Wnt/β-catenin pharmacological agonist in the cell-conditioned medium to perform chromatin immunoprecipitation (ChIP) studies in HT22 neurons.

Biochem./physiol. Wirkung

CHIR 98014 is a glycogen synthase kinase-3 (GSK-3) inhibitor with IC₅₀ values of 0.65 nM and 0.58 nM for GSK3α and GSK3β, respectively. CHIR98014 is 500-fold to >10,000-fold selectivity for GSK-3 versus 20 other protein kinases tested, including closest homologs Cdc2 and ERK2.

Rekonstituierung

Reconstitute in DMSO at 0.5 mg/mL. Following reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 6 months at -20°C.

Lagerung und Haltbarkeit

The product in the original sealed container is quite stable. It should be stored at −20°C in the powdered format.

Sicherheitshinweise

• Lagerklassenschlüssel: 11 - Combustible Solids
• WGK: WGK 3
• Flammpunkt (°F): Not applicable
• Flammpunkt (°C): Not applicable